|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Poulsen TT, Pedersen N and Poulsen HS:
Replacement and suicide gene therapy for targeted treatment of lung
cancer. Clin Lung Cancer. 6:227–236. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stuckey DW and Shah K: Stem cell-based
therapies for cancer treatment: Separating hope from hype. Nat Rev
Cancer. 14:683–691. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang TY, Huang B, Wu HB, Wu JH, Li LM, Li
YX, Hu YL, Han M, Shen YQ, Tabata Y, et al: Synergistic effects of
co-administration of suicide gene expressing mesenchymal stem cells
and prodrug-encapsulated liposome on aggressive lung melanoma
metastases in mice. J Control Release. 209:260–271. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cho WY, Hong SH, Singh B, Islam MA, Lee S,
Lee AY, Gankhuyag N, Kim JE, Yu KN, Kim KH, et al: Suppression of
tumor growth in lung cancer xenograft model mice by
poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA. Eur J
Pharm Biopharm. 94:450–462. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim I, Byeon HJ, Kim TH, Lee ES, Oh KT,
Shin BS, Lee KC and Youn YS: Doxorubicin-loaded porous PLGA
microparticles with surface attached TRAIL for the inhalation
treatment of metastatic lung cancer. Biomaterials. 34:6444–6453.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Merdan T, Kopecek J and Kissel T:
Prospects for cationic polymers in gene and oligonucleotide therapy
against cancer. Adv Drug Deliv Rev. 54:715–758. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xie RL, Jang YJ, Xing L, Zhang BF, Wang
FZ, Cui PF, Cho MH and Jiang HL: A novel potential biocompatible
hyperbranched polyspermine for efficient lung cancer gene therapy.
Int J Pharm. 478:19–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Christensen CL, Zandi R, Gjetting T,
Cramer F and Poulsen HS: Specifically targeted gene therapy for
small-cell lung cancer. Expert Rev Anticancer Ther. 9:437–452.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y, Gao DY and Huang L: In vivo
delivery of miRNAs for cancer therapy: Challenges and strategies.
Adv Drug Deliv Rev. 81:128–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen Y, Zhu X, Zhang X, Liu B and Huang L:
Nanoparticles modified with tumor-targeting scFv deliver siRNA and
miRNA for cancer therapy. Mol Ther. 18:1650–1656. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lennox KA and Behlke MA: Chemical
modification and design of anti-miRNA oligonucleotides. Gene Ther.
18:1111–1120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tivnan A, Orr WS, Gubala V, Nooney R,
Williams DE, McDonagh C, Prenter S, Harvey H, Domingo-Fernández R,
Bray IM, et al: Inhibition of neuroblastoma tumor growth by
targeted delivery of microRNA-34a using anti-disialoganglioside GD2
coated nanoparticles. PLoS One. 7:e381292012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heger Z, Gumulec J, Cernei N, Tmejova K,
Kopel P, Balvan J, Masarik M, Zitka O, Beklova M, Adam V, et al:
17β-estradiol-containing liposomes as a novel delivery system for
the antisense therapy of ER-positive breast cancer: An in vitro
study on the MCF-7 cell line. Oncol Rep. 33:921–9. 2015.PubMed/NCBI
|
|
15
|
de Jesus MB and Zuhorn IS: Solid lipid
nanoparticles as nucleic acid delivery system: Properties and
molecular mechanisms. J Control Release. 201:1–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Z, Sha X, Shen A, Wang Y, Sun Z, Gu
Z and Fang X: Polycation nanostructured lipid carrier, a novel
nonviral vector constructed with triolein for efficient gene
delivery. Biochem Biophys Res Commun. 370:478–482. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Doktorovova S, Souto EB and Silva AM:
Nanotoxicology applied to solid lipid nanoparticles and
nanostructured lipid carriers - a systematic review of in vitro
data. Eur J Pharm Biopharm. 87:1–18. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han Y, Zhang Y, Li D, Chen Y, Sun J and
Kong F: Transferrin-modified nanostructured lipid carriers as
multifunctional nanomedicine for codelivery of DNA and doxorubicin.
Int J Nanomed. 9:4107–4116. 2014.
|
|
19
|
Avitabile T, Marano F, Castiglione F,
Bucolo C, Cro M, Ambrosio L, Ferrauto C and Reibaldi A:
Biocompatibility and biodegradation of intravitreal hyaluronan
implants in rabbits. Biomaterials. 22:195–200. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fang XJ, Jiang H, Zhu YQ, Zhang LY, Fan QH
and Tian Y: Doxorubicin induces drug resistance and expression of
the novel CD44st via NF-κB in human breast cancer MCF-7 cells.
Oncol Rep. 31:2735–2742. 2014.PubMed/NCBI
|
|
21
|
Coradini D, Pellizzaro C, Abolafio G,
Bosco M, Scarlata I, Cantoni S, Stucchi L, Zorzet S, Turrin C, Sava
G, et al: Hyaluronic-acid butyric esters as promising
antineoplastic agents in human lung carcinoma: A preclinical study.
Invest New Drugs. 22:207–217. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pan J, Sun SK, Wang Y, Fu YY, Zhang X,
Zhang Y and Yu C: Facile preparation of hyaluronic acid and
transferrin co-modified Fe3O4 nanoparticles
with inherent biocompatibility for dual-targeting magnetic
resonance imaging of tumors in vivo. Dalton Trans. 44:19836–19843.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kondo H, Miyoshi K, Sakiyama S, Tangoku A
and Noma T: Differential regulation of gene expression of alveolar
epithelial cell markers in human lung adenocarcinoma-derived A549
clones. Stem Cells Int. 2015:1658672015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang W, Zhou F, Ge L, Liu X and Kong F:
Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid
carrier mediated gene delivery system for tumor-targeted
transfection. Int J Nanomed. 7:2513–2522. 2012.
|
|
25
|
Jing L, Shao S, Wang Y, Yang Y, Yue X and
Dai Z: Hyaluronic acid modified hollow Prussian blue nanoparticles
loading 10-hydroxycamptothecin for targeting thermochemotherapy of
cancer. Theranostics. 6:40–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang XG, Miao J, Dai YQ, Du YZ, Yuan H
and Hu FQ: Reversal activity of nanostructured lipid carriers
loading cytotoxic drug in multi-drug resistant cancer cells. Int J
Pharm. 361:239–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Du YZ, Cai LL, Li J, Zhao MD, Chen FY,
Yuan H and Hu FQ: Receptor-mediated gene delivery by folic
acid-modified stearic acid-grafted chitosan micelles. Int J
Nanomed. 6:1559–1568. 2011. View Article : Google Scholar
|
|
28
|
Yu W, Liu C, Liu Y, Zhang N and Xu W:
Mannan-modified solid lipid nanoparticles for targeted gene
delivery to alveolar macrophages. Pharm Res. 27:1584–1596. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang RH, Cao HM, Tian ZJ, Jin B, Wang Q,
Ma H and Wu J: Efficacy of dual-functional liposomes containing
paclitaxel for treatment of lung cancer. Oncol Rep. 33:783–791.
2015.PubMed/NCBI
|
|
30
|
Yu W, Liu C, Ye J, Zou W, Zhang N and Xu
W: Novel cationic SLN containing a synthesized single-tailed lipid
as a modifier for gene delivery. Nanotechnology. 20:2151022009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pepić I, Lovrić J, Hafner A and
Filipović-Grčić J: Powder form and stability of Pluronic mixed
micelle dispersions for drug delivery applications. Drug Dev Ind
Pharm. 40:944–951. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu X, Yang G, Shi Y, Su C, Liu M, Feng B
and Zhao L: Intracellular targeted co-delivery of shMDR1 and
gefitinib with chitosan nanoparticles for overcoming multidrug
resistance. Int J Nanomed. 10:7045–7056. 2015.
|
|
33
|
Zou W, Liu C, Chen Z and Zhang N: Studies
on bioadhesive PLGA nanoparticles: A promising gene delivery system
for efficient gene therapy to lung cancer. Int J Pharm.
370:187–195. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vighi E, Montanari M, Hanuskova M,
Iannuccelli V, Coppi G and Leo E: Design flexibility influencing
the in vitro behavior of cationic SLN as a nonviral gene vector.
Int J Pharm. 440:161–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hazzah HA, Farid RM, Nasra MM, El-Massik
MA and Abdallah OY: Lyophilized sponges loaded with curcumin solid
lipid nanoparticles for buccal delivery: Development and
characterization. Int J Pharm. 492:248–257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang L, Dong J, Ouyang W, Wang X and Tang
J: Anticancer effect and feasibility study of hyperthermia
treatment of pancreatic cancer using magnetic nanoparticles. Oncol
Rep. 27:719–726. 2012.PubMed/NCBI
|
|
37
|
Kumar MN Ravi, Bakowsky U and Lehr CM:
Preparation and characterization of cationic PLGA nanospheres as
DNA carriers. Biomaterials. 25:1771–1777. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Immordino ML, Brusa P, Rocco F, Arpicco S,
Ceruti M and Cattel L: Preparation, characterization, cytotoxicity
and pharmacokinetics of liposomes containing lipophilic gemcitabine
prodrugs. J Control Release. 100:331–346. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Song RF, Li XJ, Cheng XL, Fu AR, Wang YH,
Feng YJ and Xiong Y: Paclitaxel-loaded trimethyl chitosan-based
polymeric nanoparticle for the effective treatment of gastroenteric
tumors. Oncol Rep. 32:1481–1488. 2014.PubMed/NCBI
|
|
40
|
Torchilin VP: Multifunctional
nanocarriers. Adv Drug Deliv Rev. 58:1532–1555. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kamiya H, Tsuchiya H, Yamazaki J and
Harashima H: Intracellular trafficking and transgene expression of
viral and non-viral gene vectors. Adv Drug Deliv Rev. 52:153–164.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jiang HL, Hong SH, Kim YK, Islam MA, Kim
HJ, Choi YJ, Nah JW, Lee KH, Han KW, Chae C, et al: Aerosol
delivery of spermine-based poly(amino ester)/Akt1 shRNA complexes
for lung cancer gene therapy. Int J Pharm. 420:256–265. 2011.
View Article : Google Scholar : PubMed/NCBI
|
